Follow The Filings

THC Tenet Healthcare Corporation

Health Care, filed as TENET HEALTHCARE CORP (COM NEW), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 4 managers in 2026 Q2, sold by 2

  • 5 Owners
  • Max 7.6%
  • $482M
  • 1 new 3 add 2 exits

In 2026 Q2, 1 manager opened a position, 3 added, and 2 sold out.

Who owns this now

Largest portfolio weights among holders, up to 7.6% (Glenview Capital Management). Not free-float ownership.

  1. Glenview Capital Management Add 7.6%
  2. Eric Khrom New 3.8%
  3. Davidson Kempner Capital Mana... Add 0.19%

Who owns THC

Sorted by value, long equity only, as of 2026 Q2.

History
Glenview Capital Management 7.6%, was 7.2% Add +46.6% 2,235,666 $418M History
Eric Khrom, Khrom Capital Management 3.8% New 3.8% 244,118 $46M History
Davidson Kempner Capital Management 0.19%, was 0.03% Add +490.6% 86,815 $16M History
First Eagle Investment Management <0.01% Add +68.6% 9,133 $1.7M History
Bill Nygren / Oakmark, Harris Associates L P <0.01% Hold 2,400 $449K History
Stephen Mandel, Lone Pine Capital exited 2026 Q2 Last 2026 Q1 3.4% Exit −3.40% 2,258,717 $426M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 0.49% Exit −0.49% 452,153 $85M History

5 current, 2 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by THC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All THC insider trades
  • None no insider bought on the open market
  • $71.2M sold by 13 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. J Robert Kerrey Director
    Sale
    $3.2M 12,010 shares at $263.72 72% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  2. Richard J Mark Director
    Sale
    $2.6M 10,000 shares at $263.42 29% of stake
    Traded Sep 10 Filed Sep 14
    ↗
  3. Nadja West Director
    Sale
    $298K 1,152 shares at $258.80 4.6% of stake
    Traded Sep 2 Filed Sep 3
    ↗
  4. Lisa Y Foo COO
    Sale
    $6.4M 24,000 shares at $266.32 75% of stake
    Traded Aug 31 Filed Sep 1
    ↗
  5. Cecil D Haney Director
    Sale
    $361K 1,300 shares at $278.03 9.4% of stake
    Traded Aug 24 Filed Aug 26
    ↗
  6. Saumya Sutaria CEO
    Sale
    $27.6M 100,000 shares at $276.36 19% of stake
    Traded Aug 24–25 Filed Aug 26
    ↗
  7. Tammy Romo Director
    Sale
    $2M 7,422 shares at $263.03 21% of stake
    Traded Aug 6–7 Filed Aug 10
    ↗
  8. Roy Blunt Director
    Sale
    $158K 600 shares at $262.68 12% of stake
    Traded Aug 5 Filed Aug 7
    ↗
  9. Lisa Y Foo COO
    Sale
    $2.6M 10,000 shares at $258.03 24% of stake
    Traded Jul 29 Filed Jul 31
    ↗
  10. Christopher S. Lynch Director
    Sale
    $934K 3,837 shares at $243.44 29% of stake
    Traded Jul 27 Filed Jul 28
    ↗
  11. Paola M Arbour EVP, Chief Information Officer
    Sale
    $2.7M 10,878 shares at $243.90 37% of stake
    Traded Jul 27 Filed Jul 28
    ↗
  12. James L Bierman Director
    Sale
    $1.2M 5,000 shares at $244.96 14% of stake
    Traded Jul 27 Filed Jul 28
    ↗
  13. J Robert Kerrey Director
    Sale
    $984K 5,638 shares at $174.52 25% of stake
    Traded May 28 Filed May 29
    ↗
  14. Nadja West Director
    Sale
    $532K 3,000 shares at $177.35 11% of stake
    Traded May 27 Filed May 28
    ↗
  15. Paola M Arbour EVP, Chief Information Officer
    Sale
    $1.5M 6,500 shares at $238.43 18% of stake
    Traded Mar 11 Filed Mar 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 29 option exercises, 18 share withholdings for taxes, 8 sales back to the company, 5 stock grants, and 2 gifts.

Congress

3 members of Congress traded THC in the last three years: 4 buys and 5 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Jonathan L. Jackson D-IL-1Joint Sell $15K–$50K Apr 20 filed May 27
  2. Jonathan L. Jackson D-IL-1Spouse Sell $1K–$15K Apr 15 filed May 27
  3. Jonathan L. Jackson D-IL-1Spouse Partial sale $1K–$15K Feb 11 filed Mar 12
  4. Jonathan L. Jackson D-IL-1Joint Buy $15K–$50K Dec 10, 2025 filed Jan 8
  5. Jonathan L. Jackson D-IL-1Spouse Buy $1K–$15K Sep 3, 2025 filed Oct 15, 2025
  6. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Aug 4, 2025 filed Sep 12, 2025

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $20.55B $20.66B $21.31B

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $7.17B $7.68B $7.85B
Total non-current assets * $21.14B $21.25B $21.83B
Total assets $28.31B $28.94B $29.68B
Total current liabilities $4.76B $4.31B $4.46B
Total non-current liabilities * $18.04B $16.08B $16.24B
Total equity $1.61B $4.17B $4.22B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $2.37B $2.05B $3.54B
Cash from investing -$0.969B $3.43B -$1.28B
Cash from financing -$1.04B -$3.68B -$2.4B
Net change in cash $0.37B $1.79B -$0.136B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.